Shareholdings
| Concept |
2023-04-01 to 2024-03-31 |
As at 2024-03-31 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues | — |
7
xbrli:pure
|
| Carrying amount | — |
464,683,000
JPY
|
| Number of issues whose number of shares increased |
3
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
377,830,000
JPY
|
— |
| Reason for increase in number of shares |
再生医療、創薬、ラボシェアリングの各領域におけるベンチャー企業として、協業により当社の事業拡大につながると判断したため
|
— |
| Number of issues whose number of shares decreased |
1
xbrli:pure
|
— |
| Total sale amount for decreased shares |
JPY
|
— |
| Shares other than those not listed | ||
| Number of issues | — |
7
xbrli:pure
|
| Carrying amount | — |
1,577,225,000
JPY
|
| Number of issues whose number of shares increased |
1
xbrli:pure
|
— |
| Total acquisition cost for increased shares |
JPY
|
— |
| Reason for increase in number of shares |
保有していた非上場株式が新規上場したため
|
— |
| Number of issues whose number of shares decreased |
xbrli:pure
|
— |
| Total sale amount for decreased shares |
JPY
|
— |